Cubist Systematic Strategies, LLC Eli Lilly & CO Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 45,785 shares of LLY stock, worth $36.5 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

45,785

Previous 1,700 2593.24%

Holding current value

$36.5 Million

Previous $1.54 Million 2535.61%

% of portfolio

0.26%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $35.4 Million - $44 Million	45,785 New	45,785 $40.6 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.08 Million - $1.27 Million	2,049 Added 12.34%	18,651 $10.9 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $1.13 Million - $1.55 Million	2,590 Added 18.48%	16,602 $8.92 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $2.84 Million - $3.8 Million	8,105 Added 137.21%	14,012 $6.57 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $12.7 Million - $14.9 Million	-40,805 Reduced 87.35%	5,907 $2.03 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $5.02 Million - $5.85 Million	15,610 Added 50.19%	46,712 $17.1 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $20.8 Million - $23.8 Million	-70,300 Reduced 69.33%	31,102 $10.1 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $4.2 Million - $4.93 Million	15,062 Added 17.44%	101,402 $32.9 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $15.1 Million - $18.8 Million	64,310 Added 291.92%	86,340 $24.7 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $22.1 Million - $27.4 Million	-98,186 Reduced 81.67%	22,030 $6.09 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $22.7 Million - $27.9 Million	102,326 Added 571.97%	120,216 $27.8 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $9.75 Million - $12.6 Million	-53,988 Reduced 75.11%	17,890 $4.11 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $5.74 Million - $7.43 Million	34,950 Added 94.64%	71,878 $13.4 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $6.51 Million - $8.62 Million	-49,924 Reduced 57.48%	36,928 $6.24 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $659,598 - $762,945	4,511 Added 5.48%	86,852 $12.9 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $615,527 - $740,780	4,512 Added 5.8%	82,341 $13.5 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $8.22 Million - $10.2 Million	69,021 Added 783.62%	77,829 $10.8 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $6.24 Million - $7.72 Million	-58,328 Reduced 86.88%	8,808 $1.16 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $4.22 Million - $4.59 Million	-39,473 Reduced 37.03%	67,136 $7.51 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $4.03 Million - $4.71 Million	36,388 Added 51.82%	106,609 $11.8 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $7.73 Million - $9.1 Million	69,477 Added 9338.31%	70,221 $9.11 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $2.47 Million - $2.77 Million	-23,345 Reduced 96.91%	744 $86,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $246,589 - $308,194	2,872 Added 13.54%	24,089 $2.59 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $64,723 - $74,282	855 Added 4.2%	21,217 $1.81 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $2.03 Million - $2.4 Million	-27,411 Reduced 57.38%	20,362 $1.58 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $3.91 Million - $4.2 Million	47,773	47,773 $4.04 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Eli Lilly & CO Transaction History